177 related articles for article (PubMed ID: 38051771)
1. The TLR2/TLR6 ligand FSL-1 mitigates radiation-induced hematopoietic injury in mice and nonhuman primates.
Brickey WJ; Caudell DL; Macintyre AN; Olson JD; Dai Y; Li S; Dugan GO; Bourland JD; O'Donnell LM; Tooze JA; Huang G; Yang S; Guo H; French MN; Schorzman AN; Zamboni WC; Sempowski GD; Li Z; Owzar K; Chao NJ; Cline JM; Ting JPY
Proc Natl Acad Sci U S A; 2023 Dec; 120(50):e2122178120. PubMed ID: 38051771
[TBL] [Abstract][Full Text] [Related]
2. The Toll-Like Receptor 2/6 Agonist, FSL-1 Lipopeptide, Therapeutically Mitigates Acute Radiation Syndrome.
Kurkjian CJ; Guo H; Montgomery ND; Cheng N; Yuan H; Merrill JR; Sempowski GD; Brickey WJ; Ting JP
Sci Rep; 2017 Dec; 7(1):17355. PubMed ID: 29230065
[TBL] [Abstract][Full Text] [Related]
3. FSL-1: A Synthetic Peptide Increases Survival in a Murine Model of Hematopoietic Acute Radiation Syndrome.
Holmes-Hampton GP; Kumar VP; Valenzia K; Ghosh SP
Radiat Res; 2024 May; 201(5):449-459. PubMed ID: 38373011
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Neulasta or Neupogen on H-ARS and GI-ARS Mortality and Hematopoietic Recovery in Nonhuman Primates After 10-Gy Irradiation With 2.5% Bone Marrow Sparing.
Farese AM; Bennett AW; Gibbs AM; Hankey KG; Prado K; Jackson W; MacVittie TJ
Health Phys; 2019 Mar; 116(3):339-353. PubMed ID: 30281533
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 2 and 6 agonist fibroblast-stimulating lipopeptide increases expression and secretion of CXCL1 and CXCL2 by uveal melanocytes.
Hu DN; Zhang R; Iacob CE; Yao S; Yang SF; Chan CC; Rosen RB
Exp Eye Res; 2022 Mar; 216():108943. PubMed ID: 35074346
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting Glycogen Synthase Kinase-3 Mitigates the Hematopoietic Acute Radiation Syndrome in a Sex- and Strain-dependent Manner in Mice.
Daniel AR; Lee CL; Oh P; Luo L; Ma Y; Kirsch DG
Health Phys; 2020 Sep; 119(3):315-321. PubMed ID: 32175929
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Radiation Dose and Variation in Neupogen® Initiation Schedule on the Mitigation of Myelosuppression during the Concomitant GI-ARS and H-ARS in a Nonhuman Primate Model of High-dose Exposure with Marrow Sparing.
MacVittie TJ; Bennett AW; Farese AM; Taylor-Howell C; Smith CP; Gibbs AM; Prado K; Jackson W
Health Phys; 2015 Nov; 109(5):427-39. PubMed ID: 26425903
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting glycogen synthase kinase-3 mitigates the hematopoietic acute radiation syndrome in mice.
Lee CL; Lento WE; Castle KD; Chao NJ; Kirsch DG
Radiat Res; 2014 May; 181(5):445-51. PubMed ID: 24720754
[TBL] [Abstract][Full Text] [Related]
9. Radioprotective Efficacy of Gamma-Tocotrienol in Nonhuman Primates.
Singh VK; Kulkarni S; Fatanmi OO; Wise SY; Newman VL; Romaine PL; Hendrickson H; Gulani J; Ghosh SP; Kumar KS; Hauer-Jensen M
Radiat Res; 2016 Mar; 185(3):285-98. PubMed ID: 26930378
[TBL] [Abstract][Full Text] [Related]
10. Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of Toll-like receptor 2 (TLR2).
Shakhov AN; Singh VK; Bone F; Cheney A; Kononov Y; Krasnov P; Bratanova-Toshkova TK; Shakhova VV; Young J; Weil MM; Panoskaltsis-Mortari A; Orschell CM; Baker PS; Gudkov A; Feinstein E
PLoS One; 2012; 7(3):e33044. PubMed ID: 22479357
[TBL] [Abstract][Full Text] [Related]
11. Optimizing and Profiling Prostaglandin E2 as a Medical Countermeasure for the Hematopoietic Acute Radiation Syndrome.
Patterson AM; Wu T; Chua HL; Sampson CH; Fisher A; Singh P; Guise TA; Feng H; Muldoon J; Wright L; Plett PA; Pelus LM; Orschell CM
Radiat Res; 2021 Feb; 195(2):115-127. PubMed ID: 33302300
[TBL] [Abstract][Full Text] [Related]
12. Association of Hematological Nadirs and Survival in a Nonhuman Primate Model of Hematopoietic Syndrome of Acute Radiation Syndrome.
Gluzman-Poltorak Z; Vainstein V; Basile LA
Radiat Res; 2015 Aug; 184(2):226-30. PubMed ID: 26207689
[TBL] [Abstract][Full Text] [Related]
13. WAG/RijCmcr rat models for injuries to multiple organs by single high dose ionizing radiation: similarities to nonhuman primates (NHP).
Fish BL; MacVittie TJ; Szabo A; Moulder JE; Medhora M
Int J Radiat Biol; 2020 Jan; 96(1):81-92. PubMed ID: 30575429
[No Abstract] [Full Text] [Related]
14. The Hematopoietic Syndrome of the Acute Radiation Syndrome in Rhesus Macaques: A Systematic Review of the Lethal Dose Response Relationship.
MacVittie TJ; Farese AM; Jackson W
Health Phys; 2015 Nov; 109(5):342-66. PubMed ID: 26425897
[TBL] [Abstract][Full Text] [Related]
15. γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current Status.
Singh VK; Hauer-Jensen M
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27153057
[TBL] [Abstract][Full Text] [Related]
16. Delayed Captopril Administration Mitigates Hematopoietic Injury in a Murine Model of Total Body Irradiation.
McCart EA; Lee YH; Jha J; Mungunsukh O; Rittase WB; Summers TA; Muir J; Day RM
Sci Rep; 2019 Feb; 9(1):2198. PubMed ID: 30778109
[TBL] [Abstract][Full Text] [Related]
17. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and Biodistribution of 16,16 dimethyl Prostaglandin E2 in Non-Irradiated and Irradiated Mice and Non-Irradiated Non-Human Primates.
Langevin B; Singh P; Plett PA; Sampson CH; Masters A; Gibbs A; Faria E; Triesler S; Zodda A; Jackson IL; Orschell CM; Gopalakrishnan M; Pelus LM
Radiat Res; 2024 Jan; 201(1):7-18. PubMed ID: 38019093
[TBL] [Abstract][Full Text] [Related]
19. Thioredoxin mitigates radiation-induced hematopoietic stem cell injury in mice.
Sundaramoorthy P; Wang Q; Zheng Z; Jiao Y; Chen BJ; Doan PL; Chao NJ; Kang Y
Stem Cell Res Ther; 2017 Nov; 8(1):263. PubMed ID: 29141658
[TBL] [Abstract][Full Text] [Related]
20. Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.
Pandey SP; Chandel HS; Srivastava S; Selvaraj S; Jha MK; Shukla D; Ebensen T; Guzman CA; Saha B
J Immunol; 2014 Oct; 193(7):3632-43. PubMed ID: 25194056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
